Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Ixabepilone + Carboplatin Metastatic Breast Cancer

ClinicalTrials.gov ID: NCT01075100

Public ClinicalTrials.gov record NCT01075100. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 19, 2026, 7:46 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Ixabepilone adds significantly to the antitumor effectiveness of capecitabine in both ER+ and triple negative breast cancer. Ixabepilone has substantial antitumor activity in taxane-refractory patients and novel combinations are needed in this poor prognosis population. Carboplatin in combination with gemcitabine or paclitaxel has activity in metastatic breast cancer (MBC); there is also demonstrated activity of the gemcitabine/carboplatin combination in the ER+ versus triple negative subsets. A Phase I study of ixabepilone plus carboplatin in solid tumor patients demonstrated the safety of this combination at the doses and schedule proposed for this Phase II trial (BMS data on file).

Study identification

NCT ID
NCT01075100
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
US Oncology Research
Industry
Enrollment
103 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 2010 (Type not available)
Primary completion
Jun 2013 (Actual)
Completion
Jun 2013 (Actual)
Last update posted
Dec 7, 2016

2010 – 2013

United States locations

U.S. sites
59
U.S. states
21
U.S. cities
53
Facility City State ZIP Site status
Hematology Oncology Associates Phoenix Arizona 85012 —
Arizona Oncology Associates, PC - NAHOA Sedona Arizona 86336 —
Arizona Oncology Associates, PC - HOPE Tucson Arizona 85704 —
Southwest Cancer care Murrieta California 92562 —
Rocky Mountain Cancer Centers Denver Colorado 80220 —
Florida Cancer Institute - New Hope Hudson Florida 34667 —
Melbourne Internal Medicine Associates Melbourne Florida 32901 —
Florida Institute of Research, Medicine & Surgery Ocoee Florida 34761 —
Cancer Care & Hematology Specialists of Chicagoland Niles Illinois 60714 —
Central Indiana Cancer Centers Carmel Indiana 46032 —
Alliance Hematology Oncology, P.A. Westminster Maryland 21157 —
Minnesota Oncology Hematology, P.A. Minneapolis Minnesota 55404 —
Maryland Oncology Hematology, PA The Medical Pavillion at Howard County Columbia Missouri 21044 —
Missouri Cancer Associates Columbia Missouri 65201 —
Kansas City Cancer Center, LLC Kansas City Missouri 64131 —
St. Joseph Oncology, Inc. Saint Joseph Missouri 64507 —
Comprehensive Cancer Care Centers of Nevada Henderson Nevada 89074 —
Hematology-Oncology Associates of Northern NJ, PA Carol G. Simon Cancer Center Morristown New Jersey 07962 —
Ruth Oratz MD New York New York 10016 —
Interlakes Oncology & Hematology, P.C Rochester New York 14623 —
Raleigh Hematology Oncology Associates Raleigh North Carolina 27607 —
Dayton Oncology & Hematology, P.A. Greater Dayton Cancer Center Kettering Ohio 45409 —
Northwest Cancer Specialists, PC Portland Oregon 97213 —
Medical Oncology Associates of Wyoming Valley, PC Kingston Pennsylvania 18704 —
Cancer Centers of the Carolinas Greenville South Carolina 29605 —
Texas Oncology - Abilene Abilene Texas 79606 —
Texas Oncology - Amarillo Amarillo Texas 79106 —
Texas Oncology - Austin Midtown Austin Texas 78705 —
Texas Oncology - Bedford Bedford Texas 76022 —
Texas Oncology Medical City Dallas Dallas Texas 75230 —
Texas Oncology-Dallas Presbyterian Hospital Dallas Texas 75231 —
Texas Oncology-Methodist Charlton Cancer Center Dallas Texas 75237 —
Texas Oncology Dallas Texas 75246 —
Texas Oncology- Denton South Denton Texas 76210 —
Texas Oncology-Fort Worth 12 Ave Fort Worth Texas 76104 —
Texas Oncology-Memorial City Houston Texas 77024 —
Texas Oncology- Lewisville Lewisville Texas 75067 —
Texas Oncology-Longview Cancer Center Longview Texas 75601 —
Texas Oncology-McAllen South Second Street McAllen Texas 78509 —
Texas Oncology-Mesquite Mesquite Texas 75150 —
Texas Oncology-Midland Allison Cancer Center Midland Texas 79701 —
Texas Oncology- Odessa West Texas Cancer Center Odessa Texas 79761 —
Paris Regional Cancer Center Paris Texas 75460 —
Cancer Care Centers of South Texas San Antonio Texas 78217 —
Cancer Care Centers of South Texas-HOAST San Antonio Texas 78229 —
Texas Cancer Center - Sherman Sherman Texas 75090 —
Texas Oncology - Sugar Land Sugar Land Texas 77479 —
Texas Oncology-Tyler Tyler Texas 75702 —
Texas Oncology-Waco Waco Texas 76712 —
Texas Oncology Wichita Falls Texoma Cancer Center Wichita Falls Texas 76310 —
Virginia Oncology Associates Norfolk Virginia 23502 —
Highline Medical Oncology Burien Washington 98166 —
Puget Sound Cancer Centers Edmonds Washington 98026 —
Columbia Basin Hematology & Oncology Kennewick Washington 99336 —
Puget Sound Cancer Centers Seattle Washington 98133 —
Cancer Care Northwest Spokane Washington 99202 —
Evergreen Hematology & Oncology Spokane Washington 99218 —
Yakima Valley Memorial Hospital/North Star Lodge Yakima Washington 98902 —
Raleigh Regional Cancer Center dba Beckley Oncology Associates Inc. Beckley West Virginia 25801 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01075100, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 7, 2016 · Synced Oct 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01075100 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →